UPDATE: Markets, Regulators Not Yet United on Mifid II

Just over a week into Europe’s new financial regulatory regime, Joanne Faulkner assess the key challenges that still lie ahead as market participants and regulators alike grapple with the data and reporting requirements of Mifid II.

The European Commission’s revamp of the Markets in Financial Instruments Directive—the pan-European capital markets regulatory framework first introduced in 2007—finally arrived on Wednesday, January 3, leaving market participants facing the daunting task of reporting more data to regulators than has ever before, notably around the requirements covering transaction reports.

Under Mifid II, the scope of these reports has expanded from 24 fields under the original rulebook to 65 fields today

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

This address will be used to create your account

Removal of Chevron spells t-r-o-u-b-l-e for the C-A-T

Citadel Securities and the American Securities Association are suing the SEC to limit the Consolidated Audit Trail, and their case may be aided by the removal of a key piece of the agency’s legislative power earlier this year.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here